TYLER EDWARDS: Open Payments
NPI 1588250914 · ZACHARY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,848 in 104 payments from 15 companies in 2025. Trend: 2023 $229 · 2024 $1,615 · 2025 $1,848
Food & beverage: $1,749Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $773 |
| Janssen Biotech, Inc. | 11 | $234 |
| Lilly USA, LLC | 10 | $217 |
| GENZYME CORPORATION | 5 | $107 |
| Incyte Corporation | 5 | $98 |
| LEO Pharma Inc. | 4 | $74 |
| Arcutis Biotherapeutics, Inc. | 4 | $68 |
| Galderma Laboratories, L.P. | 4 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| PFIZER INC. | 2 | $39 |
Products named: RINVOQ, SKYRIZI, TREMFYA, TALTZ, DUPIXENT, OPZELURA, Zoryve, NEMLUVIO.
Industry payments across LA — which companies pay providers there.
